Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vaxart Inc (NQ: VXRT ) 0.7036 +0.0058 (+0.83%) Streaming Delayed Price Updated: 3:46 PM EDT, Jul 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vaxart Inc < Previous 1 2 3 4 5 6 7 8 Next > Will the Promise of Avoiding the Needle Pay Off for Vaxart? June 28, 2021 VXRT stock just received a buy recommendation and a $13 price target from Jefferies, based on the promise of a oral vaccine instead of a needle. Via InvestorPlace Exposures COVID-19 Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021 June 24, 2021 Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE: Via Benzinga Is Now The Time To Buy Stock Or Options In Apple, PayPal, Square Or Vaxart? June 24, 2021 One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why I... Via Benzinga Why Vaxart Shares Are Trading Higher Today June 11, 2021 Vaxart Inc (NASDAQ:VXRT) shares are trading higher by 30% ... Via Benzinga VXRT Stock: Can Redditors Help Vaxart Power Higher? June 18, 2021 Today, VXRT stock is climbing higher on an otherwise red day for the markets, as many speculate retail investors could be behind this rise. Via InvestorPlace Vaxart Is Still Not Worth Anywhere Near Its Present Price June 17, 2021 Vaxart is still not worth today's price. VXRT stock is worth no more than $6, especially if it's going to need another capital raise. Via InvestorPlace Exposures COVID-19 Why COVID Vaccine Stocks Dynavax, Novavax, and Vaxart Are Sinking Today June 15, 2021 The declines appear to be caused simply by volatility that's common with small biotech stocks. Via The Motley Fool Exposures COVID-19 Is It Too Late to Buy Vaxart Stock? June 15, 2021 The science looks fishy for this small-cap biotech. Via The Motley Fool Exposures COVID-19 Meme Stocks Continue To Surge As Traders Move To Biotech June 14, 2021 The meme stock crowd turned its attention to biotech and healthcare stocks, boosting some shares by as much as 10%. Via Talk Markets 64 Biggest Movers From Friday June 14, 2021 Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained... Via Benzinga Topics Initial Public Offering Exposures Securities Market VXRT Stock: Why Redditors Are Betting on a Big Squeeze With Vaxart Today June 11, 2021 VXRT stock is on the move as the company received some very bullish coverage from an analyst initiating coverage today. Via InvestorPlace Most Active Equity Options For Midday - Friday, June 11 June 11, 2021 Top tickers for midday: AMC, AAPL, TSLA, NIO, NVDA, AMZN, CLOV, SNAP, CLF, GME, PLTR, VXRT, AMD, MO, F, SENS, BAC, MSFT, BB, ET. Via Talk Markets Nasdaq, S&P 500 Eye Weekly Wins as Bond Yields Retreat June 11, 2021 The 10-year Treasury bond yield fell to a three-month low. Via Talk Markets Topics Bonds Stocks Exposures Debt Markets US Equities 46 Stocks Moving In Friday's Mid-Day Session June 11, 2021 Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67... Via Benzinga Topics Initial Public Offering Exposures Securities Market 12 Health Care Stocks Moving In Friday's Intraday Session June 11, 2021 Gainers Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million,... Via Benzinga Why Vaxart Stock Is Skyrocketing Today June 11, 2021 Investors are cheering an analyst's positive recommendation. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021 June 11, 2021 Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to... Via Benzinga Why Shares of Vaxart Plummeted 38.6% in May June 10, 2021 This isn't the first time its coronavirus vaccine pill has disappointed investors. Via The Motley Fool Exposures COVID-19 Bet on a No-Needle Vaccine Strategy with Vaxart June 09, 2021 Reimagining Covid-19 vaccines isn't an easy task, but Vaxart is prepared to innovate - and VXRT stock could move higher at any given moment. Via InvestorPlace Exposures COVID-19 10 More Current & Former Penny Stocks With High Short Interest June 08, 2021 High Short Interest Stocks Are Something Traders Are On The Hunt For & Here's Another 10 Via Talk Markets 28 Stocks Moving in Tuesday's Pre-Market Session June 08, 2021 Gainers Aytu Biopharma, Inc. (NASDAQ: AYTU) rose 37.8% to $7.40 in pre-market trading. Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) rose 23.5% to $3.89 in pre-market trading... Via Benzinga 5 High-Octane Growth Stocks With 54% to 94% Upside, According to Wall Street June 08, 2021 If analysts are correct, this assortment of rapidly growing companies could deliver big-time returns over the next year. Via The Motley Fool Topics Economy Exposures Economy These Vaccine Latecomers Could Still Win Big. Here's How June 07, 2021 The key is standing out from the crowd. Via The Motley Fool Topics Cannabis Exposures COVID-19 Cannabis Vaxart’s Compelling Story Will Take a Long Time to Play Out June 03, 2021 As a company attempting to make oral vaccines, Vaxart has a compelling story. However VXRT stock looks to be many years away from paying off. Via InvestorPlace Exposures COVID-19 With Fading Covid-19 Infections, Vaxart’s Relevance Is Waning June 02, 2021 Prior to the vaccination rollout from Vaxart’s competitors, VXRT stock appeared a compelling alternative. That’s no longer the case. Via InvestorPlace Exposures COVID-19 Speculators Should Consider Buying Vaxart Stock May 26, 2021 Vaxart's vaccine pill could prove to be effective against the original Covid-19 virus and its new variants, sending VXRT stock sky-high. Via InvestorPlace Exposures COVID-19 Vaxart Could Still Be a Viable Covid 19 Vaccine Play May 18, 2021 VXRT stock needs to nail the next few studies of its Covid-19 vaccine candidate and prove its thesis to strengthen its bull case. Via InvestorPlace Exposures COVID-19 Ocugen or Vaxart: Which Will Take Investors Further? May 15, 2021 These two high-flying biotechs are vying for the same market. Via The Motley Fool Exposures COVID-19 High Cash Burn Will Push Vaxart Stock Down To $1 Per Share May 14, 2021 Failed clinical trials and high cash burn mean Vaxart is headed down to cash per share levels. That suggests VXRT stock is worth just $1. Via InvestorPlace Exposures COVID-19 It Won’t Take Much for Vaxart Stock to Pop Once Again May 14, 2021 Vaccine stocks are risky, but Americans nervous about a shot might make the difference for VXRT stock Via InvestorPlace Exposures COVID-19 < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.